Anavex Life Sciences Corp (AVXL)

[gbrown6332]

Modest research into Kun Jin participation as a conference speaker or panelist during his FDA tenure reveals his direct association with representatives from Merck, Novartis, GlaxoSmithKline, AstraZeneca, Eli Lilly, Johnson and Johnson, Amgen, Janssen Research, Sanofi, Bristol-Myers-Squibb, Biogen, to name a few. He role as a lead FDA trial statistician likely built familiarity and intimate working knowledge of drug product submissions from a host of pharma companies across the board.

Notable he walked away from a lucrative government pension after 14 years at the FDA. His hiring by a small biotech no doubt sent shock waves through the pharma industry.

His insights will be highly valuable when weighing potential partnerships.